Description

With nearly two decades of international leadership experience, I have built a distinguished career at the intersection of ethics, compliance, internal controls, and enterprise risk management, guiding organizations across some of the world’s most complex regulatory environments. My professional journey spans 19+ years, covering Healthcare, Pharmaceuticals, Retail, FMCG, Logistics, Consumer Products, and Financial Services, with hands‑on experience across India, the Middle East, Russia, Europe, Japan, China, Africa, and the United States.

I specialize in helping organizations build resilient, future‑ready compliance ecosystems that not only protect value but also enable sustainable growth. My approach blends strategic advisory, operational excellence, digital transformation, and cross‑functional leadership, making me a trusted partner for multinational corporations, regional enterprises, and high‑growth businesses navigating risk, regulatory complexity, and organizational change.

I help organizations build strong, scalable, and future‑ready compliance and risk ecosystems that protect value, enable growth, and reinforce ethical culture. Whether supporting multinational corporations, regional businesses, or emerging enterprises, I bring a powerful combination of global experience, technical mastery, strategic insight, and transformation leadership.

My mission is simple:

To empower organizations to operate with integrity, resilience, and confidence — no matter how complex the environment.

Languages

English
Native or bilingual

Workplace preferences

Can work on-site

Dubai (up to 50km)

Pfizer Inc.
Regional Controls, Compliance and Risk Lead
PHARMACEUTICALS INDUSTRY
June 2016 - November 2025 (9 years and 5 months)
Dubai, United Arab Emirates
Member of Regional Leadership Team, driving ethics, compliance, and risk
monitoring across MERA (Includes Gulf, Levant, Saudi Arabia, South and Sub
Saharan Africa, North Africa, Egypt, CauCAR, Belarus and Russia)
• Promoted a culture of integrity and accountability through practical compliance
awareness and strong control environment.
• Served as Business Solutions Partner, advising on compliance and controls with
Commercial, Finance, Legal, and Anti‑ Corruption leaders.
• Provided strategic insights to global and regional teams, simplifying processes
and proactively resolving compliance risks.
• Led transformation projects enhancing compliance monitoring, risk management,
and operational processes across high-risk markets.
• Conducted periodic risk reviews to identify, assess, and mitigate ethical and
compliance risks.
• Developed and implemented local compliance policies and procedures across
diverse operational processes.
Reviewed and enhanced controls around all nature of transactions under Pfizer’s
Anti Bribery and Anti Corruption Policy including Business Donations, Educational Grants, Meetings, (Domestic and International) , C ha r it a bl e
Contributions, Consultancy Engagements (Speaker Programs), Patient Assistance
Programs, Product Samples, etc.
• Developed key risk and control attributes for each transaction type to be tested
during audit and risk reviews which were adapted globally.
• Led multiple discussions with Anti Corruption Program Office on key policy
changes and challenges.
• Performed annual review of local country annex (local ABAC policy) to identify
any changes based on local regulatory environment.
• Implemented local marketing code of ethics in multiple markets. (Eg. MEA
Pharmaceutical Code of Ethics for Middle East and Africa countries, MCA and
SAMED for South African markets, SFDA Code of Pharmaceutical promotion, etc.)
• Implemented Conflict of Interest Policy in the markets including annual
confirmation process.
Risk Management Ethics and Compliance Process Management Controlling and Performance Management Systems Internal Audit
Pfizer Inc.
Controls, Compliance and Risk Lead - Gulf and Levant markets
PHARMACEUTICALS INDUSTRY
June 2016 - November 2025 (9 years and 5 months)
Dubai, United Arab Emirates
• Delivered regular ethics and compliance training to regional and in-market teams, reinforcing "speak up" culture.
• Served as subject matter expert and chaired compliance focus groups, supporting governance committees on ethics, controls and risk.
• Led Third Party Focus group to rationalize global controls around third party risk management. Reviewed the Third-Party Due Diligence process for accuracy and operating effectiveness.
• Developed and rationalized Third Party work program to test attributes to minimize compliance risk.
• Enhanced local market proactive reporting and monitoring process in Russia Market focused at self identifying trend and risks aligned with specific attributes.
• Conducted healthcare compliance reviews across different transaction types across Gulf, Levant, Saudi Arabia, CauCAR, South and North Africa.
• Led the implementation of T&E Country Annex including preparing, rationalizing and standardizing local policies across all markets in the region.
• Conducted Third Party Reviews for key distributors in Gulf and Levant markets to assess the overall control and compliance environment. Tracked and assisted in timely implementation of mitigating action plans.
• Regularly presented compliance findings and risk assessment to regional leadership and board level committees.
• Assisted the global teams on developing compliance related dashboard for proactive monitoring.
• Supported and led investigations through data analysis, providing business overview, process understanding and conducting interviews across multiple violations covering anti-bribery, anti-corruption, financial controls and company policies. Assisted the business in implementing the remediation plans.
• Co-ordinating with Internal and External Audit teams
• Partnered on sustainability and ESG-related compliance initiatives, aligning governance with broader corporate responsibility goals.
Pfizer Inc.
Senior Manager - Global Corporate Audit
PHARMACEUTICALS INDUSTRY
March 2014 - June 2016 (2 years and 3 months)
Mumbai, India
Led financial and compliance (FCPA and MAPP) audits across Pfizer divisions in
Middle East and Africa, Asia, Europe, US and Latin America.
• Audited critical processes including Anti-bribery / Anti Corruption, order‑ to‑ cash, procure‑ to‑ pay, financial reporting, travel & entertainment,
and business continuity planning.
• Directed complex global projects with cross‑ border teams, ensuring consistent
compliance standards.
• Provided subject matter expertise on analytics, proc ess automation, and
compliance enhancements.
• Identified key controls, designed test plans for high‑ risk areas, and assessed
overall control environments including compensating controls.
• Performed multiple independent analyses to improve overall audit process and
cost savings.